These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2847458)

  • 41. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
    Fontcuberta J
    Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
    [No Abstract]   [Full Text] [Related]  

  • 46. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE; Kwaan HC; Szczecinski M
    J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Heparin: chemico-pharmacological characteristics].
    Ferrari L; Boffi C
    Farmaco Prat; 1975 Oct; 30(10):461-77. PubMed ID: 1104374
    [No Abstract]   [Full Text] [Related]  

  • 49. [General mechanisms of coagulation and their physiological inhibition. II. The regulation of coagulation by physiological inhibitors].
    Guillin MC; Bezeaud A
    Pathol Biol (Paris); 1985 Nov; 33(9):917-32. PubMed ID: 2867516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Heparin and antithrombin III (author's transl)].
    Kambayashi J; Chang SW; Ohno H; Kobayashi T; Kosaki G
    Rinsho Ketsueki; 1981 Jul; 22(7):1010-5. PubMed ID: 7328760
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of heparin in current therapy of thrombotic disease].
    Komarnicki M
    Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization.
    Fareed J; Walenga JM; Hoppensteadt D; Racanelli A; Coyne E
    Semin Thromb Hemost; 1989 Oct; 15(4):440-63. PubMed ID: 2554505
    [No Abstract]   [Full Text] [Related]  

  • 53. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 54. [Role of the substrate-binding portion of the active center of alpha-thrombin in excitation of the secondary anticoagulating system].
    Kudriashov BA; Umarova BA; Strukova SM; Liapina LA
    Dokl Akad Nauk SSSR; 1979; 248(2):485-8. PubMed ID: 487934
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemistry and pharmacology of heparin.
    Ehrlich J; Stivala SS
    J Pharm Sci; 1973 Apr; 62(4):517-44. PubMed ID: 4121531
    [No Abstract]   [Full Text] [Related]  

  • 56. Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
    Harenberg J; Würzner B; Zimmermann R; Schettler G
    Thromb Res; 1986 Nov; 44(4):549-54. PubMed ID: 3798415
    [No Abstract]   [Full Text] [Related]  

  • 57. Structure and function of antithrombin III.
    Koide T
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1875-84. PubMed ID: 3915413
    [No Abstract]   [Full Text] [Related]  

  • 58. A method for rapid quantitation and preparation of antithrombin III--high-affinity heparin fractions.
    Takahashi HK; Nader HB; Dietrich CP
    Anal Biochem; 1981 Sep; 116(2):456-61. PubMed ID: 7316178
    [No Abstract]   [Full Text] [Related]  

  • 59. [Heparin-urea complex and its physicochemical properties].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1975; 21(2):165-8. PubMed ID: 1138503
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.
    Lane DA; MacGregor IR; VanRoss M; Cella G; Kakkar VV
    Thromb Res; 1979; 16(5-6):651-62. PubMed ID: 524315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.